Clinical studies recruiting near Mulhouse

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Observational Study Protocol: LIVER-R
Phase N/A · Research Site · AstraZeneca · NCT06252753 Non-Invasive Ventilation Versus High-flow Nasal Oxygen in Intensive Care Units
NA · Emile Muller Hospital · Poitiers University Hospital · NCT05686850 Efficacy Investigation of the Medical Device Apneal® on Smartphone for Sleep Apnea-Hypopnea Syndrome Diagnosis
NA · Cabinet de médecine du sommeil - Cabsom · Mitral · NCT06578390 Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Seve
Phase N/A · GHR Mulhouse Sud-Alsace · Esteve Pharmaceuticals, S.A. · NCT00903110 FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
Phase 2 · GHRMSA, hôpital Emile Muller · Centre Leon Berard · NCT06393816 Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma
Phase 2 · Hopital E. Muller- Ghrmsa · University Hospital, Lille · NCT05572229 Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Phase 3 · Groupe Hospitalier de la Region de Mulhouse et Sud Alsace Hô · Kura Oncology, Inc. · NCT07007312 Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hype
Phase 3 · Department of Nephrology, Régional Hospital of Mulhouse · University Hospital, Tours · NCT05732727 This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate
Phase N/A · GHRMSA - Hospital Emile Muller-Site Number : 2500006 · Sanofi · NCT07290803 Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac
Phase 3 · Hoptial Mulhouse · Versailles Hospital · NCT06835491 Prospective National Cohort Evaluating Predictive Biomarkers of Resistance to Immunotherapy in Patients With MSI/dMMR Me
Phase N/A · Centre Hospitalier · Federation Francophone de Cancerologie Digestive · NCT06353854 REal World Data in LYmphoma and Survival in Adults
Phase N/A · Service Hématologie, GH REGION MULHOUSE ET SUD ALSACE - HOPI · Hospices Civils de Lyon · NCT03869619 Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy f
Phase 3 · MULHOUSE CH Emile Muller · Federation Francophone de Cancerologie Digestive · NCT06207981 A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Phase 3 · Ch de Mulhouse - Hăpital Emile Muller · Daiichi Sankyo · NCT06203210 Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previo
Phase 2 · Mulhouse - GHRMSA · Intergroupe Francophone de Cancerologie Thoracique · NCT06840834 Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stag
Phase 2 · Mulhouse - GHRMSA · Intergroupe Francophone de Cancerologie Thoracique · NCT06656598 Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Du
NA · CH de Mulhouse · Centre Hospitalier Universitaire de Besancon · NCT06796114 Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
NA · GHR Mulhouse Sud-Alsace - Service de Pneumologie · University Hospital, Strasbourg, France · NCT04720339 A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Particip
Phase 3 · hopital Emile Muller - Service Pneumologie · Bayer · NCT06452277 A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Phase N/A · Hopital Emile Muller · Pfizer · NCT05689151 Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combina
Phase 2/Phase 3 · Hopital Emile Muller · Mirati Therapeutics Inc. · NCT04613596 Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immu
Phase 3 · Hôpital Emile Muller · OSE Immunotherapeutics · NCT06472245 OBServatory of Compassionate Use of IVOsidenib in France for Patients With Acute Myeloid Leukemia
Phase N/A · Mulhouse Chu · French Innovative Leukemia Organisation · NCT06377579 Maintenance Pembrolizumab at Usual or Low doSE in Non-squamous Lung Cancer: a Non-inferiority Study
Phase 3 · Groupe Hospitalier de la Région de Mulhouse et Sud Alsace · Gustave Roussy, Cancer Campus, Grand Paris · NCT05692999 Determination of Epigenetic Markers of Acute Myeloblastic Leukemia in Elderly Patients
NA · Groupe Hospitalier de la Région de Mulhouse et Sud Alsace · Groupe Hospitalier de la Region de Mulhouse et Sud Alsace · NCT07250217 Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for L
Phase 2/Phase 3 · GHRMSA Hopital Emile Muller · BioNTech SE · NCT06712316 Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Bl
Phase 2 · MULHOUSE GHRMSA - Hôpital E. Muller - Hématologie · French Innovative Leukemia Organisation · NCT07007052 An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small
Phase N/A · Le Groupe Hospitalier de la Region de Mulhouse et Sud Alsace · Regeneron Pharmaceuticals · NCT05363319 CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk AML Stratified by Genomics
Phase 2 · Groupe hospitalier de la région de Mulhouse et Sud-Alsace, H · Centre Hospitalier Universitaire de Nice · NCT05260528 Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens
Phase 2/Phase 3 · CH Mulhouse · University Hospital, Angers · NCT02416388

Look up another city

Look up another condition